The announcement of the collaboration with Merck, a major player in the pharmaceutical industry, is a positive development for Ginkgo Bioworks. This partnership could potentially lead to advancements in biologic manufacturing, which would be beneficial for Ginkgo Bioworks. As a result, investors are reacting positively, leading to a rise in the company's shares.